ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AT1 Receptor Antagonists Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-29A6958
Home | Market Reports | Health| Pharmacy
Global AT1 Receptor Antagonists Market Insights and Forecast to 2028
BUY CHAPTERS

Global AT1 Receptor Antagonists Market Research Report 2025

Code: QYRE-Auto-29A6958
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol–Myers Squibb
Bayer
GSK
Teva Pharmaceutical

AT1 Receptor Antagonists Market

The global market for AT1 Receptor Antagonists was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
AT1 receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
North American market for AT1 Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AT1 Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of AT1 Receptor Antagonists include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for AT1 Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AT1 Receptor Antagonists.
The AT1 Receptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AT1 Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AT1 Receptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of AT1 Receptor Antagonists Market Report

Report Metric Details
Report Name AT1 Receptor Antagonists Market
Segment by Type
  • Valsartan
  • Telmisartan
  • Losartan
  • Irbesartan
  • Azilsartan
  • Olmesartan
Segment by Application
  • Hypertension
  • Cardiovascular Diseases
  • Kidney Diseases
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, Teva Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of AT1 Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of AT1 Receptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the AT1 Receptor Antagonists Market report?

Ans: The main players in the AT1 Receptor Antagonists Market are Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, Teva Pharmaceutical

What are the Application segmentation covered in the AT1 Receptor Antagonists Market report?

Ans: The Applications covered in the AT1 Receptor Antagonists Market report are Hypertension, Cardiovascular Diseases, Kidney Diseases, Other

What are the Type segmentation covered in the AT1 Receptor Antagonists Market report?

Ans: The Types covered in the AT1 Receptor Antagonists Market report are Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

1 AT1 Receptor Antagonists Market Overview
1.1 Product Definition
1.2 AT1 Receptor Antagonists by Type
1.2.1 Global AT1 Receptor Antagonists Market Value Comparison by Type (2024 VS 2031)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 AT1 Receptor Antagonists by Application
1.3.1 Global AT1 Receptor Antagonists Market Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Global AT1 Receptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global AT1 Receptor Antagonists Revenue 2020-2031
1.4.2 Global AT1 Receptor Antagonists Sales 2020-2031
1.4.3 Global AT1 Receptor Antagonists Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 AT1 Receptor Antagonists Market Competition by Manufacturers
2.1 Global AT1 Receptor Antagonists Sales Market Share by Manufacturers (2020-2025)
2.2 Global AT1 Receptor Antagonists Revenue Market Share by Manufacturers (2020-2025)
2.3 Global AT1 Receptor Antagonists Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of AT1 Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of AT1 Receptor Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of AT1 Receptor Antagonists, Product Type & Application
2.7 Global Key Manufacturers of AT1 Receptor Antagonists, Date of Enter into This Industry
2.8 Global AT1 Receptor Antagonists Market Competitive Situation and Trends
2.8.1 Global AT1 Receptor Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest AT1 Receptor Antagonists Players Market Share by Revenue
2.8.3 Global AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global AT1 Receptor Antagonists Market Scenario by Region
3.1 Global AT1 Receptor Antagonists Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global AT1 Receptor Antagonists Sales by Region: 2020-2031
3.2.1 Global AT1 Receptor Antagonists Sales by Region: 2020-2025
3.2.2 Global AT1 Receptor Antagonists Sales by Region: 2026-2031
3.3 Global AT1 Receptor Antagonists Revenue by Region: 2020-2031
3.3.1 Global AT1 Receptor Antagonists Revenue by Region: 2020-2025
3.3.2 Global AT1 Receptor Antagonists Revenue by Region: 2026-2031
3.4 North America AT1 Receptor Antagonists Market Facts & Figures by Country
3.4.1 North America AT1 Receptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America AT1 Receptor Antagonists Sales by Country (2020-2031)
3.4.3 North America AT1 Receptor Antagonists Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe AT1 Receptor Antagonists Market Facts & Figures by Country
3.5.1 Europe AT1 Receptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe AT1 Receptor Antagonists Sales by Country (2020-2031)
3.5.3 Europe AT1 Receptor Antagonists Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific AT1 Receptor Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific AT1 Receptor Antagonists Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific AT1 Receptor Antagonists Sales by Region (2020-2031)
3.6.3 Asia Pacific AT1 Receptor Antagonists Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America AT1 Receptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America AT1 Receptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America AT1 Receptor Antagonists Sales by Country (2020-2031)
3.7.3 Latin America AT1 Receptor Antagonists Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa AT1 Receptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa AT1 Receptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa AT1 Receptor Antagonists Sales by Country (2020-2031)
3.8.3 Middle East and Africa AT1 Receptor Antagonists Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global AT1 Receptor Antagonists Sales by Type (2020-2031)
4.1.1 Global AT1 Receptor Antagonists Sales by Type (2020-2025)
4.1.2 Global AT1 Receptor Antagonists Sales by Type (2026-2031)
4.1.3 Global AT1 Receptor Antagonists Sales Market Share by Type (2020-2031)
4.2 Global AT1 Receptor Antagonists Revenue by Type (2020-2031)
4.2.1 Global AT1 Receptor Antagonists Revenue by Type (2020-2025)
4.2.2 Global AT1 Receptor Antagonists Revenue by Type (2026-2031)
4.2.3 Global AT1 Receptor Antagonists Revenue Market Share by Type (2020-2031)
4.3 Global AT1 Receptor Antagonists Price by Type (2020-2031)
5 Segment by Application
5.1 Global AT1 Receptor Antagonists Sales by Application (2020-2031)
5.1.1 Global AT1 Receptor Antagonists Sales by Application (2020-2025)
5.1.2 Global AT1 Receptor Antagonists Sales by Application (2026-2031)
5.1.3 Global AT1 Receptor Antagonists Sales Market Share by Application (2020-2031)
5.2 Global AT1 Receptor Antagonists Revenue by Application (2020-2031)
5.2.1 Global AT1 Receptor Antagonists Revenue by Application (2020-2025)
5.2.2 Global AT1 Receptor Antagonists Revenue by Application (2026-2031)
5.2.3 Global AT1 Receptor Antagonists Revenue Market Share by Application (2020-2031)
5.3 Global AT1 Receptor Antagonists Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer AT1 Receptor Antagonists Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis AT1 Receptor Antagonists Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck AT1 Receptor Antagonists Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Astra Zeneca
6.4.1 Astra Zeneca Company Information
6.4.2 Astra Zeneca Description and Business Overview
6.4.3 Astra Zeneca AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astra Zeneca AT1 Receptor Antagonists Product Portfolio
6.4.5 Astra Zeneca Recent Developments/Updates
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Company Information
6.5.2 Jhonson and Johnson Description and Business Overview
6.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jhonson and Johnson AT1 Receptor Antagonists Product Portfolio
6.5.5 Jhonson and Johnson Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly AT1 Receptor Antagonists Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi AT1 Receptor Antagonists Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb AT1 Receptor Antagonists Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer AT1 Receptor Antagonists Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK AT1 Receptor Antagonists Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Company Information
6.11.2 Teva Pharmaceutical Description and Business Overview
6.11.3 Teva Pharmaceutical AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Teva Pharmaceutical AT1 Receptor Antagonists Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 AT1 Receptor Antagonists Industry Chain Analysis
7.2 AT1 Receptor Antagonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 AT1 Receptor Antagonists Production Mode & Process Analysis
7.4 AT1 Receptor Antagonists Sales and Marketing
7.4.1 AT1 Receptor Antagonists Sales Channels
7.4.2 AT1 Receptor Antagonists Distributors
7.5 AT1 Receptor Antagonists Customer Analysis
8 AT1 Receptor Antagonists Market Dynamics
8.1 AT1 Receptor Antagonists Industry Trends
8.2 AT1 Receptor Antagonists Market Drivers
8.3 AT1 Receptor Antagonists Market Challenges
8.4 AT1 Receptor Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol–Myers Squibb
Bayer
GSK
Teva Pharmaceutical
List of Tables
 Table 1. Global AT1 Receptor Antagonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global AT1 Receptor Antagonists Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global AT1 Receptor Antagonists Market Competitive Situation by Manufacturers in 2024
 Table 4. Global AT1 Receptor Antagonists Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global AT1 Receptor Antagonists Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global AT1 Receptor Antagonists Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global AT1 Receptor Antagonists Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market AT1 Receptor Antagonists Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of AT1 Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of AT1 Receptor Antagonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of AT1 Receptor Antagonists, Product Type & Application
 Table 12. Global Key Manufacturers of AT1 Receptor Antagonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global AT1 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AT1 Receptor Antagonists as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global AT1 Receptor Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global AT1 Receptor Antagonists Sales by Region (2020-2025) & (K MT)
 Table 18. Global AT1 Receptor Antagonists Sales Market Share by Region (2020-2025)
 Table 19. Global AT1 Receptor Antagonists Sales by Region (2026-2031) & (K MT)
 Table 20. Global AT1 Receptor Antagonists Sales Market Share by Region (2026-2031)
 Table 21. Global AT1 Receptor Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global AT1 Receptor Antagonists Revenue Market Share by Region (2020-2025)
 Table 23. Global AT1 Receptor Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global AT1 Receptor Antagonists Revenue Market Share by Region (2026-2031)
 Table 25. North America AT1 Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America AT1 Receptor Antagonists Sales by Country (2020-2025) & (K MT)
 Table 27. North America AT1 Receptor Antagonists Sales by Country (2026-2031) & (K MT)
 Table 28. North America AT1 Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America AT1 Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe AT1 Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe AT1 Receptor Antagonists Sales by Country (2020-2025) & (K MT)
 Table 32. Europe AT1 Receptor Antagonists Sales by Country (2026-2031) & (K MT)
 Table 33. Europe AT1 Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe AT1 Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific AT1 Receptor Antagonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific AT1 Receptor Antagonists Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific AT1 Receptor Antagonists Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific AT1 Receptor Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific AT1 Receptor Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America AT1 Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America AT1 Receptor Antagonists Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America AT1 Receptor Antagonists Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America AT1 Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America AT1 Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa AT1 Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa AT1 Receptor Antagonists Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa AT1 Receptor Antagonists Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa AT1 Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa AT1 Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global AT1 Receptor Antagonists Sales (K MT) by Type (2020-2025)
 Table 51. Global AT1 Receptor Antagonists Sales (K MT) by Type (2026-2031)
 Table 52. Global AT1 Receptor Antagonists Sales Market Share by Type (2020-2025)
 Table 53. Global AT1 Receptor Antagonists Sales Market Share by Type (2026-2031)
 Table 54. Global AT1 Receptor Antagonists Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global AT1 Receptor Antagonists Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global AT1 Receptor Antagonists Revenue Market Share by Type (2020-2025)
 Table 57. Global AT1 Receptor Antagonists Revenue Market Share by Type (2026-2031)
 Table 58. Global AT1 Receptor Antagonists Price (USD/MT) by Type (2020-2025)
 Table 59. Global AT1 Receptor Antagonists Price (USD/MT) by Type (2026-2031)
 Table 60. Global AT1 Receptor Antagonists Sales (K MT) by Application (2020-2025)
 Table 61. Global AT1 Receptor Antagonists Sales (K MT) by Application (2026-2031)
 Table 62. Global AT1 Receptor Antagonists Sales Market Share by Application (2020-2025)
 Table 63. Global AT1 Receptor Antagonists Sales Market Share by Application (2026-2031)
 Table 64. Global AT1 Receptor Antagonists Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global AT1 Receptor Antagonists Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global AT1 Receptor Antagonists Revenue Market Share by Application (2020-2025)
 Table 67. Global AT1 Receptor Antagonists Revenue Market Share by Application (2026-2031)
 Table 68. Global AT1 Receptor Antagonists Price (USD/MT) by Application (2020-2025)
 Table 69. Global AT1 Receptor Antagonists Price (USD/MT) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Pfizer AT1 Receptor Antagonists Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Novartis AT1 Receptor Antagonists Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Merck AT1 Receptor Antagonists Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Astra Zeneca Company Information
 Table 86. Astra Zeneca Description and Business Overview
 Table 87. Astra Zeneca AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Astra Zeneca AT1 Receptor Antagonists Product
 Table 89. Astra Zeneca Recent Developments/Updates
 Table 90. Jhonson and Johnson Company Information
 Table 91. Jhonson and Johnson Description and Business Overview
 Table 92. Jhonson and Johnson AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Jhonson and Johnson AT1 Receptor Antagonists Product
 Table 94. Jhonson and Johnson Recent Developments/Updates
 Table 95. Eli Lilly Company Information
 Table 96. Eli Lilly Description and Business Overview
 Table 97. Eli Lilly AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Eli Lilly AT1 Receptor Antagonists Product
 Table 99. Eli Lilly Recent Developments/Updates
 Table 100. Sanofi Company Information
 Table 101. Sanofi Description and Business Overview
 Table 102. Sanofi AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Sanofi AT1 Receptor Antagonists Product
 Table 104. Sanofi Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb AT1 Receptor Antagonists Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Bayer AT1 Receptor Antagonists Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. GSK AT1 Receptor Antagonists Product
 Table 119. GSK Recent Developments/Updates
 Table 120. Teva Pharmaceutical Company Information
 Table 121. Teva Pharmaceutical Description and Business Overview
 Table 122. Teva Pharmaceutical AT1 Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Teva Pharmaceutical AT1 Receptor Antagonists Product
 Table 124. Teva Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. AT1 Receptor Antagonists Distributors List
 Table 128. AT1 Receptor Antagonists Customers List
 Table 129. AT1 Receptor Antagonists Market Trends
 Table 130. AT1 Receptor Antagonists Market Drivers
 Table 131. AT1 Receptor Antagonists Market Challenges
 Table 132. AT1 Receptor Antagonists Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of AT1 Receptor Antagonists
 Figure 2. Global AT1 Receptor Antagonists Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global AT1 Receptor Antagonists Market Share by Type: 2024 & 2031
 Figure 4. Valsartan Product Picture
 Figure 5. Telmisartan Product Picture
 Figure 6. Losartan Product Picture
 Figure 7. Irbesartan Product Picture
 Figure 8. Azilsartan Product Picture
 Figure 9. Olmesartan Product Picture
 Figure 10. Global AT1 Receptor Antagonists Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global AT1 Receptor Antagonists Market Share by Application: 2024 & 2031
 Figure 12. Hypertension
 Figure 13. Cardiovascular Diseases
 Figure 14. Kidney Diseases
 Figure 15. Other
 Figure 16. Global AT1 Receptor Antagonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global AT1 Receptor Antagonists Market Size (2020-2031) & (US$ Million)
 Figure 18. Global AT1 Receptor Antagonists Sales (2020-2031) & (K MT)
 Figure 19. Global AT1 Receptor Antagonists Average Price (USD/MT) & (2020-2031)
 Figure 20. AT1 Receptor Antagonists Report Years Considered
 Figure 21. AT1 Receptor Antagonists Sales Share by Manufacturers in 2024
 Figure 22. Global AT1 Receptor Antagonists Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest AT1 Receptor Antagonists Players: Market Share by Revenue in AT1 Receptor Antagonists in 2024
 Figure 24. AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global AT1 Receptor Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America AT1 Receptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 27. North America AT1 Receptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe AT1 Receptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 31. Europe AT1 Receptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 32. Germany AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific AT1 Receptor Antagonists Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Region (2020-2031)
 Figure 39. China AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America AT1 Receptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 50. Latin America AT1 Receptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E AT1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of AT1 Receptor Antagonists by Type (2020-2031)
 Figure 60. Global Revenue Market Share of AT1 Receptor Antagonists by Type (2020-2031)
 Figure 61. Global AT1 Receptor Antagonists Price (USD/MT) by Type (2020-2031)
 Figure 62. Global Sales Market Share of AT1 Receptor Antagonists by Application (2020-2031)
 Figure 63. Global Revenue Market Share of AT1 Receptor Antagonists by Application (2020-2031)
 Figure 64. Global AT1 Receptor Antagonists Price (USD/MT) by Application (2020-2031)
 Figure 65. AT1 Receptor Antagonists Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renin Angiotensin System RAS Inhibitor Market Research Report 2024
Global Sartans Market Research Report 2024
lrbesartan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global Irbesartan Market Research Report 2024
Global Bradykinin Receptor Antagonists Market Research Report 2024
Global Angiotensin II Receptor Blockers Market Insights Forecast to 2030
Global Irbesartan Tablets Market Insights Forecast to 2030
Global Androgen Receptor AR Antagonist Market Research Report 2024
Global Losartan Potassium API Market Research Report 2024
Global Non Peptide Drugs of Angiotensin II Receptor Antagonist Market Research Report 2024
Valsartan Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Angiotensin II Receptor Blocker ARBs API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Valsartan Hydrochlorothiazide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Valsartan Capsules Market Research Report 2024
Global Renin Inhibitors Market Research Report 2025
Global Irbesartan API Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions